Interestingly, epigenetic inactivation of DLX4 by DNA methylation has been proved in chronic lymphocytic leukemia (CLL) and several other solid tumors [19–23]. This evidence concerns the gene DLX4 and B-cell chronic lymphocytic leukemia.